Expert panel likely to meet this week to decide on Sputnik V's emergency use
The union government's expert panel on new drugs and vaccines could meet later this week to consider granting emergency approval to Sputnik V, Russia's Covid-19 vaccine, a report in ThePrint said citing sources. Hyderabad-based drugmaker Dr. Reddy's Laboratories, which conducted the clinical trials for the vaccine, has submitted the immunogenicity data to the subject expert committee (SEC) of the Central Drugs Standards Control Organisation (CDSCO), India's national regulatory body for pharmaceuticals and medical devices. Read more here
Odisha facing a shortage of